Thursday, April 23, 2026 at 10 a.m. ET. CALL PARTICIPANTS. President and Chief Executive Officer — James L. Eccher; Chief ...
The next evolution of the finance function isn’t about controlling cybersecurity spend; it’s about controlling cyber exposure ...
Munich, Germany, April 23, 2026 - Vivoryon Therapeutics N.V. (Euronext Amsterdam: VVY; NL00150002Q7) (Vivoryon), a clinical stage company developing small molecule medicines for inflammatory and ...
NervGen Pharma Corp., a clinical-stage biopharmaceutical company developing first-in-class neuroreparative therapeutics for spinal cord injury (SCI) and other neurotraumatic and neurologic conditions, ...
MaxLinear announces first quarter 2026 financial results ...
United Rentals, Inc. (NYSE: URI) today announced financial results for the first quarter of 2026, including record first quarter total revenue, rental revenue(1) , earnings per share ("EPS") and ...
This is a useful study that seeks to elucidate the molecular mechanisms underlying spinal motor circuit assembly. The authors demonstrate that loss of Onecut transcription factors in spinal motor ...
This valuable study addressed a key question in epilepsy research: whether the recordings of very fast oscillations in the brain (>250Hz, fast ripples) reflect underlying pathology or might be a ...
Group sales were +6% at constant exchange rates (CER)1, -5% when reported in CHF and +9% in USD2, in the first three months, driven by high demand for our innovative medicines and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results